INTERCONT.H.LS-,208521303/ GB00BHJYC057 /
21/05/2024 21:43:23 | Var. -1.000 | Volume | Denaro21/05/2024 | Lettera21/05/2024 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
92.000EUR | -1.08% | 2 Fatturato: 184 |
91.000Quantità in denaro: 500 | 92.500Quantità in lettera: 500 | 15.73 bill.EUR | - | - |
GlobeNewswire
07:30
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...
GlobeNewswire
07:30
Aalberts N.V.: Aalberts sustained added value margin in challenging market environment
GlobeNewswire
07:25
Trial carbon capture unit begins operating on Blast Furnace at ArcelorMittal Gent, Belgium
GlobeNewswire
07:00
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire
07:00
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA app...
GlobeNewswire
04:45
INDEPENDENT BANK INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC ...
GlobeNewswire
04:45
GLOBE LIFE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS IN...
GlobeNewswire
04:44
OVERSEAS SHIPHOLDING INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, ...
GlobeNewswire
04:34
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS...
GlobeNewswire
04:32
LINCOLN NATIONAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMI...